4d Molecular Therapeutics In shares owned by Legal & General Group
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Legal & General Group
from 13F filings
Historical chart of Legal & General Group investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by Legal & General Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $32k | 3.7k | 8.69 |
| 2025-06-30 | $14k | 3.7k | 3.71 |
| 2025-03-31 | $41k | 13k | 3.23 |
| 2024-12-31 | $191k | 34k | 5.57 |
| 2024-09-30 | $368k | 34k | 10.81 |
| 2024-06-30 | $657k | 31k | 20.99 |
| 2024-03-31 | $802k | 25k | 31.83 |
| 2023-12-31 | $497k | 25k | 20.26 |
| 2023-09-30 | $311k | 24k | 12.73 |
| 2023-06-30 | $437k | 24k | 18.07 |
| 2023-03-31 | $122k | 7.1k | 17.19 |
| 2022-12-31 | $63k | 2.8k | 22.21 |
| 2022-09-30 | $75k | 9.4k | 8.00 |
| 2022-06-30 | $66k | 9.4k | 7.01 |
| 2022-03-31 | $125k | 8.2k | 15.18 |
| 2021-12-31 | $181k | 8.2k | 21.92 |
| 2021-09-30 | $149k | 5.5k | 27.08 |
| 2021-06-30 | $20k | 814 | 24.57 |
| 2021-03-31 | $34k | 792 | 42.93 |